Furthermore, the aforementioned study of melanoma cell lines found that rare cells express resistance genes (e.g., EGFR, AXL, or WNT5A) at high levels and that these cells are far more likely to become tolerant once a drug is applied [47]. Here, AXL is linked to melanoma.